Evolution of Pseudomonas aeruginosa virulence in infected patients revealed in a Dictyostelium discoideum host model  by Lelong, E. et al.
Evolution of Pseudomonas aeruginosa virulence in infected patients
revealed in a Dictyostelium discoideum host model
E. Lelong1, A. Marchetti1, M. Simon1, J. L. Burns2, C. van Delden3, T. Ko¨hler3 and P. Cosson1
1) Department of Cell Physiology and Metabolism, Centre Me´dical Universitaire, Geneva Faculty of Medicine, Geneva, Switzerland, 2) Division of Infectious
Diseases, Department of Pediatrics, University of Washington, Seattle Children’s Research Institute, Seattle, WA, USA and 3) Service of Infectious Diseases,
University Hospital Geneva, Geneva, Switzerland
Abstract
Pseudomonas aeruginosa can cause acute lung infections in intubated patients or chronic infections in patients with cystic ﬁbrosis (CF).
In both situations, P. aeruginosa accumulates speciﬁc mutations, in particular in the lasR quorum-sensing regulator gene. Using a
Dictyostelium discoideum amoeba model, we assessed whether these mutations affect bacterial virulence. Among a collection of clinical
isolates from 16 CF patients, initial isolates were fully virulent in 15 patients, but for late isolates collected several years later, virulence
was decreased in eight patients. No signiﬁcant correlation between genetic inactivation of lasR and decreased virulence was observed.
Among strains isolated from ten colonized intubated patients, all initial isolates were fully virulent. Despite the accumulation of lasR-inac-
tivating mutations in strains collected over a 3-week period, no decrease in virulence was observed in eight of 10 patients. In one
intubated patient, the virulent initial strain was replaced a few days later with a different, less virulent, strain. We observed a gradual
decrease in bacterial virulence in only one intubated patient. We conclude that adaptation of P. aeruginosa to chronically infected CF
patients can lead to a slow and gradual loss of virulence, as measured in a Dictyostelium model system. However, loss of virulence is not
caused predominantly by mutations in lasR. During short-term colonization of intubated patients for up to 20 days, a decrease in
virulence was exceptional, despite the accumulation of lasR mutations.
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Introduction
Pseudomonas aeruginosa is a bacterial pathogen responsible
for a wide variety of infections, in particular in hospitalized
patients, or individuals with cystic ﬁbrosis (CF) [1]. P. aerugin-
osa mutates and adapts rapidly to a changing environment. In
a seminal study [2], two P. aeruginosa isolates collected from
a CF patient with a 7.5-year interval were fully sequenced,
and 68 mutations were identiﬁed in the later isolate. Thir-
teen of these mutations affected genes potentially implicated
in virulence, including lasR, which encodes a central regulator
of the quorum-sensing (QS) circuit, and exsA, which encodes
the regulator of the type III secretion system (TTSS). These
mutations were also found to be frequent in late P. aerugin-
osa isolates from CF patients [2]. Remarkably, in P. aeruginosa
isolates colonizing intubated patients, lasR-inactivating muta-
tions accumulate within days, suggesting that this evolution
can be extremely rapid [3]. Although these observations sug-
gest that airway persistence of P. aeruginosa may be linked to
decreased virulence, the pathogenicity of these strains was
not tested. Thus, whether bacterial virulence effectively
changes during airway colonization and chronic infections
remains an open question.
Changes in bacterial virulence in such clinical settings can
be detected experimentally by systematically testing the viru-
lence of sequential P. aeruginosa isolates. However, it is
difﬁcult to envisage such extensive analyses using rodent
infection models, for both practical and ethical reasons.
Non-mammalian host models do not suffer from these
limitations, and many studies have shown that they provide
an accurate measure of P. aeruginosa virulence [4]. Previous
studies have established that P. aeruginosa uses essentially the
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same virulence pathways, in particular those of the QS and
the TTSS systems, to infect mice and Dictyostelium discoideum
amoebae [4–6]. Indeed, amoebae are natural predators of
P. aeruginosa, and the bacterial pathogenic mechanisms may
have developed primarily as defence systems [7,8]. In the
present study, we used this non-mammalian host model to
assess the dynamics of P. aeruginosa virulence during coloni-




P. aeruginosa strains isolated from CF patients [2] or intubated
patients [3] have been described previously. Control strains
were included in every test: PAO1 (PT5) and two isogenic QS
mutants, PT462 (rhlR) and PT531 (rhlR–lasR) [4]. In agreement
with previously published results, the virulence scores for
these strains were 8, 2 and 0, respectively.
The D. discoideum cells used in this study were sub-
clone DH1-10 of the DH1 strain [9]. D. discoideum cells were
grown at 21C in HL5 medium [10].
Bacterial virulence assay
Bacterial virulence was determined essentially as previously
described [10]. Brieﬂy, P. aeruginosa isolates were streaked
on LB plates and grown at 37C, and individual colonies
were then grown overnight (18 h) in 3 mL of LB, at 37C
with shaking. The very few isolates (<1%) that did not reach
high cell densities (OD600 nm > 3) were not analysed further.
Fifty microlitres of this culture was deposited on 2 mL of
SM50%-Agar (5 g/L peptone, 0.5 g/L yeast extract, 1.1 g/L
KH2PO4, 0.5 g/L K2HPO4, 0.5 g/L MgSO4.7H2O, 5 g/L glu-
cose, 20 g/L agar) in each well of a 24-well plate. Five micro-
litres of HL5 containing 10 000, 1000, 100 or ten
D. discoideum cells was added to the bacterial lawn, and the
plate was incubated at 25C. D. discoideum growth was
followed for 10 days.
Results
Evolution of virulence during chronic P. aeruginosa infections
in CF patients
We ﬁrst analysed the virulence of previously characterized
isolates from 16 CF patients chronically infected with P. aeru-
ginosa [2]. For this, we used D. discoideum as a model host as
previously described [10], but with a few variations,
described below, that provided a more quantitative measure
of bacterial virulence. Growth of D. discoideum cells on bac-
teria was assessed at two different times (days 4 and 10)
(Fig. 1). The results (from 0 to 4) of these two time points
were added, and the virulence of P. aeruginosa strains was
scored on a scale between 0 (avirulent) and 8 (highly
virulent). In addition, as some clinical isolates are mixtures of
different clones, we tested at least six individual clones for
each clinical isolate.
With the exception of patient 14, all early isolates of
P. aeruginosa from CF patients were virulent in our model
(Fig. 2). For eight patients (patients 1, 4, 5, 6, 10, 11, 15 and
16), we observed no decrease in virulence in isolates
collected at older ages (Fig. 2). We analysed the virulence of
all 35 isolates available from patient 1, in which most of the
initial genetic analysis was performed [2]. Although only a
few of the results are shown in Fig. 2, all of these isolates
were virulent, indicating that the mutations previously identi-
ﬁed in this strain did not cause a signiﬁcant loss of virulence
in the D. discoideum host model.
For the seven other patients (patients 2, 3, 7, 8, 9, 12 and
13), at least one late isolate was signiﬁcantly less virulent
(Fig. 2). Although a few isolates (e.g. in patient 12) showed
uniformly avirulent phenotypes, we often observed a wide
range of intermediate virulence levels when different clones
of the same isolate were tested. None of these hetero-
geneous isolates corresponded to a characterized mutator
isolate [11], suggesting that these results reﬂected the hetero-





FIG. 1. Measuring the virulence of Pseudomonas aeruginosa. The viru-
lence of bacteria was determined by their ability to prevent growth
of Dictyostelium discoideum. D. discoideum cells (10 000, 1 000, 100
or 10) were deposited on a lawn of bacteria in a 24-well plate.
D. discoideum cells grew on avirulent bacteria and created a phagocy-
tic plaque (white). To score the virulence, we determined, at days 4
and 10, the number of wells in which growth of D. discoideum was
inhibited. The ﬁnal virulence score was obtained by adding up the
scores for days 4 and 10, yielding a number ranging from 0 (aviru-
lent) to 8 (fully virulent). (a) PT5. (b) isolate 4A from patient 15 101.
(c) PT462. (d) PT531 [4].
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virulence of individual clones did not vary signiﬁcantly
(Fig. S1). We also conﬁrmed that all clones from a given
patient belonged to the same genotype by testing selected
clones by random ampliﬁed polymorphic DNA analysis
(Fig. S2).
Mutations inactivating lasR are frequently found among late
CF isolates [2]. Strikingly, we observed no correlation
between lasR inactivation and loss of virulence (Fig. 2). For
example, some isolates for which all clones analysed were
virulent exhibited lasR mutations (e.g. patient 15, 12.8A and
12.8B). Conversely, wild-type lasR was observed in some
avirulent isolates (e.g. patient 12, 21.1A). Overall, the
decrease in virulence between early and late isolates was sta-
tistically signiﬁcant, as revealed by a Wilcoxon matched-pairs
signed rank test (p <0.02). However, no statistically signiﬁ-
cant association between lasR inactivation and loss of viru-
lence in the D. discoideum host model could be established
(chi-square test, p >0.1). Although these results do not
formally rule out an inﬂuence of lasR genetic inactivation on
virulence, they indicate that lasR mutations represent, at
most, a minor contributory factor in the evolution of bacte-
rial virulence in chronically infected patients.
FIG. 2. Virulence of Pseudomonas aeruginosa isolates from cystic ﬁbrosis (CF) patients. The virulence of P. aeruginosa isolates collected from 16
different CF patients at different ages was determined as described in Fig. 1. Several individual clones were tested for each isolate (each dot rep-
resents one clone). Stars indicate isolates with lasR-inactivating mutations [2].
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Virulence of P. aeruginosa colonizing intubated patients
In order to study the short-term evolution of virulence in a
different clinical context, we analysed 116 isolates of P. aeru-
ginosa collected previously from ten colonized, mechanically
ventilated patients [3]. We have shown that these isolates
accumulated mutations within days, affecting in particular the
lasR QS system. This was notably the case for isolates from
patients 13 121, 13 122, 19 105 and 30 101. On the con-
trary, in patients 05 101, 13 104 and 13 111, no lasR mutants
were reported. For all of these patients, we observed that
the initial isolate (day 0) and all later isolates were fully viru-
lent against D. discoideum (Fig. 3a,b), indicating that loss of
lasR did not affect virulence in this host model.
In two patients, 15 101 and 27 101, we observed isolates
with attenuated virulence and analysed them in more detail.
Previous studies established that all isolates from patient
27 101 had mutations in lasR and rhlR [3]. In the D. discoide-
um host model, the early isolate of patient 27 101 was viru-
lent, but a heterogeneous virulence pattern was seen after a
few days of colonization, and this was maintained throughout
the period of observation (Fig. 3c). The appearance of fully
avirulent clones (score = 0) at later times of colonization
suggested a rapid evolution towards reduced virulence in this
particular patient.
As described previously [3], patient 15 101 was initially
colonized with a strain genotyped as OC2E, but this strain
was replaced rapidly with strain 239A. Whereas the OC2E
isolates were uniformly virulent against D. discoideum, 239A
isolates exhibited a mixture of very virulent and almost non-
virulent clones (Fig. 3d). Over the course of colonization,
this heterogeneous proﬁle of virulence was maintained, and
no clear evolution towards a less virulent population pheno-
type was observed. In this patient, original observations
showed the presence of lasR mutations in many but not all
isolates. For six isolates (days 4, 6, 7, 8, 14 and 17), we iso-
lated two clones (A and B), sequenced their lasR genes, and
determined their virulence in the D. discoideum host model
(Fig. 3e). In four instances (days 6, 7, 8 and 14), lasR-inacti-
vated clones were less virulent than non-mutant clones, but
there were two exceptions to this rule: clone 4A had a non-
mutated lasR and reduced virulence, and clone 17A had a
mutant lasR and a high virulence.
Discussion
In this study, we used D. discoideum as a model host to ana-
lyse the virulence of P. aeruginosa and to test the widely
accepted notion that P. aeruginosa virulence decreases rapidly
in chronically infected or colonized patients, a prediction
based on previous reports of accumulation of mutations with
a potential effect on bacterial virulence [2,3]. The results
published to date indicate a perfect correlation between the
ability of P. aeruginosa to harm acutely infected rodents (i.e.
its virulence) and its ability to inhibit Dictyostelium growth. It
should, however, be kept in mind that no single assay is
likely to reﬂect every facet of P. aeruginosa virulence, and
that some traits critical for virulence of P. aeruginosa in
human lungs may not be revealed in a Dictyostelium model.
Our results indicate, ﬁrst, that virtually all early P. aerugin-
osa isolates from CF or from intubated patients were
virulent. Second, the rapid emergence of non-virulent
mutants of P. aeruginosa during the ﬁrst weeks of colonization
was highly unusual in intubated patients. Indeed, we observed
a gradual change towards less virulent phenotypes in only
one intubated patient (patient 27 101). Third, after several
years of chronic infection, we did observe the emergence of
clones with reduced virulence in approximately half of the CF
patients analysed. In many cases, isolates with mixed virulence
phenotypes were seen, suggesting that even after the appear-
ance of avirulent clones, the change in the population was
slow and gradual. A similar observation was made in two
intubated patients (27 101 and 15 101), where virulent and
avirulent clones coexisted over the whole period of observa-
tion. Extensive analysis will be necessary to determine
whether these mixed populations represent only a transi-
tional phase in the development of uniformly avirulent popu-
lations, or a stable situation corresponding to a complex
equilibrium between virulent and avirulent bacterial clones.
Our interpretation of these results is that, within
colonized and chronically infected patients, loss of bacterial
virulence is not the main driving force for the rapid adapta-
tion to the human lung shown by the accumulation of lasR
mutations. On the other hand, virulence does not seem to
provide a critical long-term advantage to the bacteria, as it
was markedly lower in many late isolates. From a selection
point of view, expression of virulence traits thus appears to
be essentially neutral, and bacterial virulence may gradually
drift over a period of several years in the environment of
the human lung. It seems likely that survival of P. aeruginosa
in the lungs requires traits other than virulence, at least as
measured in a Dictyostelium assay. Indeed, previous studies
have suggested that some isolates from CF patients are still
capable of colonizing mouse lungs, although their virulence
(i.e. their negative effect on mouse survival) is strongly
reduced [12].
If P. aeruginosa virulence is not critical for its survival in
human lungs, why were initial isolates virulent? Bacterial viru-
lence may be essential at the initial stage of colonization, but
less important once colonization is established. The strong
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virulence of initial isolates could also reﬂect the fact that
they originate from the environment, where they are under
strong selective pressure from environmental predators
(including amoebae). Accordingly, some bacterial virulence
traits may be dispensable in the human lung, where environ-






FIG. 3. Virulence of Pseudomonas aeruginosa isolates from intubated patients. One hundred and sixteen P. aeruginosa isolates collected at daily
intervals from ten intubated patients [3] were analysed as described in Fig. 1. (a) All isolates from patient 19 105 were fully virulent. A represen-
tative sample of all the isolates tested is shown. (b) For all patients listed, all isolates analysed were fully virulent, even though many had lasR-
inactivating mutations (stars). (c) Many isolates from patient 27 101 exhibited clones with decreased virulence. Six individual clones were tested
for each isolate (each dot represents one clone). (d) Patient 15 101 was infected initially with strain OC2E, which was replaced after a few days
with strain 239A. Isolates of strain OC2E were all virulent, whereas isolates of strain 239A exhibited heterogeneous virulence levels. (e) To eval-
uate the effect of lasR mutations on the virulence of 239A clones, individual colonies were analysed for the presence of lasR mutations, and their
virulence was tested. *lasR mutated clone. ND, not determined; WT, wild type.
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A separate issue is the nature of the mutations that
caused the loss of virulence of P. aeruginosa clinical strains.
Our results suggest that lasR mutations played, at most, a
minor role, as we observed many lasR-defective isolates that
remained virulent in the D. discoideum host model. This was
most striking in patient 13 116, where all isolates exhibited a
double lasR/rhlR inactivation, a genotype that would cause a
complete loss of QS-dependent virulence in a PAO1 strain,
yet where all isolates remained virulent against D. discoideum.
It is also worth noting that this patient was one of the few
in whom pneumonia eventually developed, indicating that this
strain did have a strong pathogenic potential in humans.
Many factors contribute to P. aeruginosa virulence (e.g. QS,
the TTSS or motility) [1]. It will be particularly interesting in
the future to sequence the genomes of clones exhibiting
reduced virulence, and to compare them with those of their
closest virulent relatives. This analysis may shed light on the
mechanisms controlling the evolution of bacterial virulence in
clinical strains.
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